117 related articles for article (PubMed ID: 20099058)
1. Insufficient evaluation of adverse events is not a proof of safety.
Hemkens LG; Grouven U; Bender R; Sawicki PT
Diabetologia; 2010 Apr; 53(4):790-2; author reply 793-4. PubMed ID: 20099058
[No Abstract] [Full Text] [Related]
2. Treatment of adolescents with type 1 diabetes mellitus.
Garg S; Chase HP
J Pediatr Endocrinol Metab; 2004 May; 17(5):805-6. PubMed ID: 15237718
[No Abstract] [Full Text] [Related]
3. Combined randomised controlled trial experience of malignancies in studies using insulin glargine.
Home PD; Lagarenne P
Diabetologia; 2009 Dec; 52(12):2499-506. PubMed ID: 19756478
[TBL] [Abstract][Full Text] [Related]
4. Glargine and lispro: two cases of mistaken identity.
Adlersberg MA; Fernando S; Spollett GR; Inzucchi SE
Diabetes Care; 2002 Feb; 25(2):404-5. PubMed ID: 11815523
[No Abstract] [Full Text] [Related]
5. Diabetes treatment with insulin glargine and risk of malignancy: methodological pitfalls and ethical issues.
Simon D
Diabetologia; 2010 Jan; 53(1):204-5. PubMed ID: 19859691
[No Abstract] [Full Text] [Related]
6. Insulin glargine: commentary on the duration of action and lower risk of nocturnal hypoglycaemia in patients with diabetes.
Rosenstock J; Owens D
Expert Opin Pharmacother; 2004 Jan; 5(1):1-2; author reply 2-3. PubMed ID: 14680430
[No Abstract] [Full Text] [Related]
7. No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis.
Dejgaard A; Lynggaard H; Råstam J; Krogsgaard Thomsen M
Diabetologia; 2009 Dec; 52(12):2507-12. PubMed ID: 19838665
[TBL] [Abstract][Full Text] [Related]
8. Insulin glargine controversy: a tribute to the editorial team at Diabetologia.
Butler PC
Diabetes; 2009 Nov; 58(11):2427-8. PubMed ID: 19875618
[No Abstract] [Full Text] [Related]
9. Diabetic retinopathy and insulin glargine.
Chantelau E
Diabetologia; 2009 Oct; 52(10):2233; author reply 2236-9. PubMed ID: 19680626
[No Abstract] [Full Text] [Related]
10. Insulin resistance and increased risk for malignant neoplasms: confounding of the data on insulin glargine.
Nagel JM; Mansmann U; Wegscheider K; Röhmel J
Diabetologia; 2010 Jan; 53(1):206-8. PubMed ID: 19774358
[No Abstract] [Full Text] [Related]
11. Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study.
Hemkens LG; Grouven U; Bender R; Günster C; Gutschmidt S; Selke GW; Sawicki PT
Diabetologia; 2009 Sep; 52(9):1732-44. PubMed ID: 19565214
[TBL] [Abstract][Full Text] [Related]
12. Insulin glargine and the risk of cancer.
Ahmed FA
Cardiovasc J Afr; 2010; 21(1):49. PubMed ID: 20224847
[No Abstract] [Full Text] [Related]
13. Insulin detemir (levemir), a new long-acting insulin.
Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022
[TBL] [Abstract][Full Text] [Related]
14. Nausea and vomiting due to insulin glargine in patient with type 1 diabetes mellitus.
Dixon AN; Bain SC
BMJ; 2005 Feb; 330(7489):455. PubMed ID: 15731143
[No Abstract] [Full Text] [Related]
15. Insulin glargine: a systematic review of a long-acting insulin analogue.
Wang F; Carabino JM; Vergara CM
Clin Ther; 2003 Jun; 25(6):1541-77, discussion 1539-40. PubMed ID: 12860485
[TBL] [Abstract][Full Text] [Related]
16. A possible link between insulin glargine and malignancy: the facts.
Mollentze WF
Cardiovasc J Afr; 2009; 20(4):216-8; discussion 218-9. PubMed ID: 19701528
[No Abstract] [Full Text] [Related]
17. [Increased risk of cancer using insulin and insulin analogues?].
Schäffler A
MMW Fortschr Med; 2010 Sep; 152(36):39-41. PubMed ID: 21192466
[No Abstract] [Full Text] [Related]
18. Insulin glargine: a long-acting insulin for diabetes mellitus.
Garces K
Issues Emerg Health Technol; 2003 Nov; (52):1-4. PubMed ID: 14626260
[TBL] [Abstract][Full Text] [Related]
19. Insulin glargine and cancer--an unsubstantiated allegation.
Garg SK; Hirsch IB; Skyler JS
Diabetes Technol Ther; 2009 Aug; 11(8):473-6. PubMed ID: 19591544
[No Abstract] [Full Text] [Related]
20. Where now for insulin glargine--a time for pragmatic medicine?
Thomson GA; Craig R
Int J Clin Pract; 2009 Oct; 63(10):1413-5. PubMed ID: 19689485
[No Abstract] [Full Text] [Related]
[Next] [New Search]
